Zantac Litigation
Zantac Litigation
Have you or a loved one taken Zantac or its generic version, Ranitidine, to treat your heartburn or indigestion related issues?
The FDA has recalled Zantac and all generic versions due to concerns of N-nitrosodimethylamine (NDMA) found in the products. NDMA is classified as a probable human carcinogen by the International Agency for Research on Cancer. The maker of these cancer-causing pills must be held accountable.
Signs of NDMA exposure include jaundice, abdominal pain/cramps, liver enlargement, reduced organ function, and dizziness. Exposure to NDMA from Zantac or Ranitidine may result in cancer, including:
- Bladder Cancer
- Breast Cancer
- Colon/Colorectal Cancer
- Endometrial/Uterine Cancer
- Esophageal/Throat/Nasal Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Non-Hodgkin’s Lymphoma
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Stomach Cancer
- Testicular Cancer
- Thyroid Cancer
If you or a loved one have taken Zantac or Ranitidine for 6 months or more, and have experience the above symptoms or cancers, you may have a claim.
Our team of lawyers is ready to fight for you through this process, contact us now for a FREE case evaluation.
